SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022005
Filing Date
2020-05-06
Accepted
2020-05-06 16:43:32
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q Q1 03312020 harp-10q_20200331.htm 10-Q 2567316
2 EX-31.1 harp-ex311_7.htm EX-31.1 17876
3 EX-31.2 harp-ex312_9.htm EX-31.2 18844
4 EX-32.1 harp-ex321_8.htm EX-32.1 7089
  Complete submission text file 0001564590-20-022005.txt   8451724

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT harp-20200331.xml EX-101.INS 1968898
6 XBRL TAXONOMY EXTENSION SCHEMA harp-20200331.xsd EX-101.SCH 49881
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20200331_cal.xml EX-101.CAL 45045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20200331_def.xml EX-101.DEF 181070
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20200331_lab.xml EX-101.LAB 394835
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20200331_pre.xml EX-101.PRE 310006
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 20853243
SIC: 2836 Biological Products, (No Diagnostic Substances)